Literature DB >> 32193179

Double hit: Evans syndrome after malignant thymoma treatment and parvovirus B19 infection.

John Xie1, Gerard Chaaya2, Rachna Jetly-Shridhar3, Thomas Stewart Atkinson4.   

Abstract

Malignancies are often associated with autoimmune diseases, which are addressed by treating the underlying cancer. However, there are rare malignancies that can cause autoimmune diseases even after appropriate treatment. Our patient is a 39-year-old Hispanic man with a malignant thymoma recently treated with chemotherapy and radiation who presented with syncope and dyspnoea. He was found to be both anaemic and thrombocytopenic. His labs were consistent with autoimmune haemolytic anaemia (AIHA), except his reticulocyte count was unexpectedly low. Bone marrow biopsy supported a diagnosis of Evans syndrome, a rare autoimmune condition characterised by (AIHA) combined with immune thrombocytopenia. He was also found to have an acute parvovirus B19 infection. He was treated with steroids and RBC transfusion. His blood counts gradually returned to baseline, with improvement in symptoms. This patient's thymoma treatment and active parvovirus B19 infection likely both played a role in the development of Evans syndrome. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  haematology (incl blood transfusion); oncology

Mesh:

Substances:

Year:  2020        PMID: 32193179      PMCID: PMC7101047          DOI: 10.1136/bcr-2019-233485

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

1.  Parvovirus B19 in idiopathic thrombocytopenic purpura.

Authors:  A Wehmeier; A M Eis-Hübinger; M Maas Enriquez; H Beckmann
Journal:  Vox Sang       Date:  2000       Impact factor: 2.144

2.  Autoimmune hemolytic anemia and autoimmune hepatitis associated with parvovirus B19 infection.

Authors:  Valerio Nobili; Sandro Vento; Donatella Comparcola; Maria Rita Sartorelli; Matteo Luciani; Matilde Marcellini
Journal:  Pediatr Infect Dis J       Date:  2004-02       Impact factor: 2.129

3.  Parvovirus B19-associated haemophagocytosis in Evans syndrome: aplastic crisis accompanied by severe thrombocytopenia.

Authors:  N Uike; T Miyamura; K Obama; H Takahira; H Sato; M Kozuru
Journal:  Br J Haematol       Date:  1993-07       Impact factor: 6.998

4.  Human parvovirus B19 associated with idiopathic thrombocytopenic purpura.

Authors:  Orhan Cem Aktepe; Sevgi Yetgin; Lale Olcay; Namik Ozbek
Journal:  Pediatr Hematol Oncol       Date:  2004 Jul-Aug       Impact factor: 1.969

5.  Variability of the erythropoietic response in autoimmune hemolytic anemia: analysis of 109 cases.

Authors:  J L Liesveld; J M Rowe; M A Lichtman
Journal:  Blood       Date:  1987-03       Impact factor: 22.113

6.  Development of systemic lupus erythematosus after chemotherapy and radiotherapy for malignant thymoma.

Authors:  A Rosman; T Atsumi; M A Khamashta; P R Ames; G R Hughes
Journal:  Br J Rheumatol       Date:  1995-12

7.  A case of pure red cell aplasia complicated by Evans syndrome.

Authors:  Yasuhiko Toyokawa; Isamu Kingetsu; Chiho Yasuda; Jun Yasuda; Ken Yoshida; Daitaro Kurosaka; Akio Yamada
Journal:  Mod Rheumatol       Date:  2007-08-20       Impact factor: 3.023

8.  Autoimmune hemolytic anemia with reticulocytopenia. A medical emergency.

Authors:  C L Conley; S M Lippman; P Ness
Journal:  JAMA       Date:  1980-10-10       Impact factor: 56.272

9.  Thymic epithelial tumor complicated by immunological abnormalities: results from a single-center retrospective study in China.

Authors:  Tian-Yan Shi; Xiao-Hong Wen; Xu-Hua Shi; Yue-Wu Lu
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

10.  Parvovirus B19-triggered Acute Hemolytic Anemia and Thrombocytopenia in a Child with Evans Syndrome.

Authors:  Panagiota Zikidou; Anastassia Grapsa; Zoe Bezirgiannidou; Athanassios Chatzimichael; Elpis Mantadakis
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-03-01       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.